Product Details
Product Name:
Besifovir PM |
Purity:
99.80% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Besifovir PM |
Description | Besifovir PM (LB80331 PM) is an analogue of Besifovir, a novel orally available acyclic nucleotide phosphonate for the treatment of chronic hepatitis B infection. |
Storage | Shipping with blue ice. |
Solubility Information | DMSO : 10 mg/mL (42.87 mM)
|
Keywords | Besifovir PM |
Inhibitors Related | Doxorubicin hydrochloride | Osthole | RO8191 | Tenofovir Disoproxil Fumarate | Thiamine hydrochloride | 4,5-Dicaffeoylquinic acid | 4-Hydroxyacetophenone | Telbivudine | Tenofovir | Bifendate |
Related Compound Libraries | Bioactive Compound Library | Anti-Viral Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1009832-82-9
$693.00 / 10μg
-
CAS:1191237-49-6
$133.00 / 1mg
-
CAS:89419-23-8
$197.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$1400.00/10ton |
VIP1Y
|
ChemFine International Co.,Ltd.
|
2024-07-25 |
|
$1670.00/25mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |
|
$99.00/1EA |
|
Amikon Limited
|
2018-10-11 |